2-99188180-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145212.4(MRPL30):c.55G>A(p.Val19Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,587,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145212.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL30 | NM_145212.4 | c.55G>A | p.Val19Met | missense_variant | 3/6 | ENST00000338148.8 | NP_660213.1 | |
MRPL30 | NR_028356.2 | n.148G>A | non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL30 | ENST00000338148.8 | c.55G>A | p.Val19Met | missense_variant | 3/6 | 1 | NM_145212.4 | ENSP00000338057 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000324 AC: 75AN: 231212Hom.: 0 AF XY: 0.000328 AC XY: 41AN XY: 124968
GnomAD4 exome AF: 0.000171 AC: 246AN: 1435056Hom.: 0 Cov.: 30 AF XY: 0.000172 AC XY: 123AN XY: 713948
GnomAD4 genome AF: 0.000184 AC: 28AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.55G>A (p.V19M) alteration is located in exon 3 (coding exon 2) of the MRPL30 gene. This alteration results from a G to A substitution at nucleotide position 55, causing the valine (V) at amino acid position 19 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at